Published in
Springer, Dermatology and Therapy, 11(13), p. 2697-2719, 2023
DOI: 10.1007/s13555-023-01016-9
Links
Tools
Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis
Journal article published in 2023 by
Michael J. Cork,
Diamant Thaçi,
Lawrence F. Eichenfield,
Peter D. Arkwright,
Zhen Chen,
Ryan B. Thomas,
Matthew P. Kosloski,
Ariane Dubost-Brama,
Randy Prescilla,
Ashish Bansal,
Noah A. Levit 
This paper is made freely available by the publisher.
Full text: Download
Data provided by 